Influenza Diagnostic Tests Market Report

RA00536

Influenza Diagnostic Tests Market, by End Use (Hospitals, Clinical Laboratories, Other End-User), Type (Traditional Diagnostic Tests, Molecular Diagnostic Tests): Global Opportunity Analysis and Industry Forecast, 2020-2027

RA00536

Pages: NA

Jan 2021

The report presents a comprehensive analysis of the global influenza diagnostic tests market by thoroughly examining several facets of the market including market drivers and restraints, key segments, major geographies, significant players, and competitive lookout.

The report portrays a detailed scenario of the current conditions and future scope of the global influenza diagnostic tests market based on various factors and events that impact market growth. The report highlights major drivers and opportunities which are contributing to the growth of the market. In addition, drawbacks and limitations that restrict the market growth are also deliberated in the report. The report also provides Porter’s five forces analysis which describes the factors affecting profitability of the global influenza diagnostic tests market.

The report furnishes market scope, size, and predictions by evaluating the major segments and sub-segments of the global influenza diagnostic tests market. Furthermore, the report highlights regional market scenario and scope of these segments by studying every market segment at regional and country level. The report classifies the global influenza diagnostic tests market into four main regions including Asia-Pacific, North America, Europe, and LAMEA. These regions are further sub-classified into countries to explain the country-level scenario and scope of the market.

In addition, the report provides competitive landscape of the global influenza diagnostic tests market. The foremost players functioning in the global influenza diagnostic tests market are premeditated in the report to comprehend their present position and dominance in the market. Moreover, the report provides various insights regarding these players such as company overview, company officials, financial status, key business strategies, novel initiatives and developments by the companies to withstand and upkeep their status in the global influenza diagnostic tests market.

Research Methodology

Our reports are formulated by expert, in-house market analysts by performing meticulous research and analysis on a variety of market facts, major events, and data-points including industry players’ interviews, consistent information from renowned sources, and regional insights. The market professionals have keen knowledge about various research methodologies, tools, and analysis. They use advanced analytical models and tools to filter the data and statistics and enhance the precision of the forecasts of the market.

This report has been articulated after long hours of deliberations, analysis, and interviews with several leading market stakeholders and players. A huge pile of product type literatures, annual reports, industry news, and other related pieces of information from significant industry participants have been studied for obtaining profound knowledge of the market. A combination of primary and secondary research has been applied for predicting the market statistics and forecasts. Secondary research methods focus on an extensive range of activities such as data mining of certified data sources including medical journals, trade association’s releases, independent studies, technical journals, and materials published by government and regulatory authorities.

KEY MARKET BENEFITS

The report is a collation of meticulous market statistics and dynamics, data-points from market contributors and industry experts functioning in the industry, and quantitative and qualitative assessment by market analysts

This report offers comprehensive breakdown of present market trends, governing factors, and macro-economic indicators from 2019 to 2027 to detect & comprehend the prevalent opportunities in the global influenza diagnostic tests market

The report outlines the qualitative authority of numerous aspects on market segments as well as regions

The market forecasts and future scope offered in the report are derived after complete analysis of latest & innovative advances in the influenza diagnostic tests market

The growth and development strategies adopted by the prominent industry players are enlisted in the report to understand the competitive scenario of the influenza diagnostic tests market

KEY MARKET SEGMENTS

The global influenza diagnostic tests market is segmented based on the following:

End Use: Hospitals, Clinical Laboratories, Other End-User

Type: Traditional Diagnostic Tests, Molecular Diagnostic Tests

This segment is further sub-segmented into the following regions:

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA

KEY MARKET PLAYERS

The global influenza diagnostic tests market is highly competitive due to the existence of several major players in the industry. These players have brought in innovative and advanced products/services to obtain a foremost position in the market. The report outlines numerous factors of top ten key players such as recent strategic moves & developments, financial performance, product portfolio, and SWOT analysis.

Key players in the global influenza diagnostic tests market are as follows:

1. F. Hoffmann-La Roche AG

2. Quidel Corporation

3. Thermo Fisher Scientific

4. Abbott Laboratories

5. Hologic

6. Becton, Dickinson, and Company

7. DiaSorin S.p.A

8. Luminex Corporation

9. Meridian Bioscience

10. GenMark Diagnostics

11. SA Scientific

12. Sekisui Diagnostics

13. bioM

1. RESEARCH METHODOLOGY
- 1.1. Desk Research
- 1.2. Real time insights and validation
- 1.3. Forecast model
- 1.4. Assumptions and forecast parameters
- 1.5. Market size estimation
  - 1.5.1. Top-down approach
  - 1.5.2. Bottom-up approach
2. REPORT SCOPE
- 2.1. Market definition
- 2.2. Key objectives of the study
- 2.3. Report overview
- 2.4. Market segmentation
- 2.5. Overview of the impact of COVID-19 on Global Influenza Diagnostic Tests Market
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
- 4.1. Introduction
- 4.2. Growth impact forces
  - 4.2.1. Drivers
  - 4.2.2. Restraints
  - 4.2.3. Opportunities
- 4.3. Market value chain analysis
  - 4.3.1. List of raw material suppliers
  - 4.3.2. List of manufacturers
  - 4.3.3. List of distributors
- 4.4. Innovation & sustainability matrices
  - 4.4.1. Technology matrix
  - 4.4.2. Regulatory matrix
- 4.5. Porter’s five forces analysis
  - 4.5.1. Bargaining power of suppliers
  - 4.5.2. Bargaining power of consumers
  - 4.5.3. Threat of substitutes
  - 4.5.4. Threat of new entrants
  - 4.5.5. Competitive rivalry intensity
- 4.6. PESTLE analysis
  - 4.6.1. Political
  - 4.6.2. Economical
  - 4.6.3. Social
  - 4.6.4. Technological
  - 4.6.5. Environmental
- 4.7. Impact of COVID-19 on Influenza Diagnostic Tests Market
  - 4.7.1. Pre-covid market scenario
  - 4.7.2. Post-covid market scenario
5. Influenza Diagnostic Tests Market, By End Use
- 5.1. Overview
- 5.2 Hospitals
  - 5.2.1 Definition, key trends, growth factors, and opportunities
  - 5.2.2 Market size analysis, by region, 2020-2027
  - 5.2.3 Market share analysis, by country, 2020-2027
- 5.3 Clinical Laboratories
  - 5.3.1 Definition, key trends, growth factors, and opportunities
  - 5.3.2 Market size analysis, by region, 2020-2027
  - 5.3.3 Market share analysis, by country, 2020-2027
- 5.4 Other End-User
  - 5.4.1 Definition, key trends, growth factors, and opportunities
  - 5.4.2 Market size analysis, by region, 2020-2027
  - 5.4.3 Market share analysis, by country, 2020-2027
- 5.5 Research Dive Exclusive Insights
  - 5.5.1 Market attractiveness
  - 5.5.2 Competition heatmap
6. Influenza Diagnostic Tests Market, By Type
- 6.1. Overview
- 6.2 Traditional Diagnostic Tests
  - 6.2.1 Definition, key trends, growth factors, and opportunities
  - 6.2.2 Market size analysis, by region, 2020-2027
  - 6.2.3 Market share analysis, by country, 2020-2027
- 6.3 Molecular Diagnostic Tests
  - 6.3.1 Definition, key trends, growth factors, and opportunities
  - 6.3.2 Market size analysis, by region, 2020-2027
  - 6.3.3 Market share analysis, by country, 2020-2027
- 6.4 Research Dive Exclusive Insights
  - 6.4.1 Market attractiveness
  - 6.4.2 Competition heatmap
7. Influenza Diagnostic Tests Market, By Region
- 7.1 North America
  - 7.1.1 U.S
    - 7.1.1.1 Market size analysis, By End Use, 2020-2027
    - 7.1.1.2 Market size analysis, By Type, 2020-2027
  - 7.1.2 Canada
    - 7.1.2.1 Market size analysis, By End Use, 2020-2027
    - 7.1.2.2 Market size analysis, By Type, 2020-2027
  - 7.1.3 Mexico
    - 7.1.3.1 Market size analysis, By End Use, 2020-2027
    - 7.1.3.2 Market size analysis, By Type, 2020-2027
  - 7.1.4 Research Dive Exclusive Insights
    - 7.1.4.1 Market attractiveness
    - 7.1.4.2 Competition heatmap
- 7.2 Europe
  - 7.2.1 Germany
    - 7.2.1.1 Market size analysis, By End Use, 2020-2027
    - 7.2.1.2 Market size analysis, By Type, 2020-2027
  - 7.2.2 UK
    - 7.2.2.1 Market size analysis, By End Use, 2020-2027
    - 7.2.2.2 Market size analysis, By Type, 2020-2027
  - 7.2.3 France
    - 7.2.3.1 Market size analysis, By End Use, 2020-2027
    - 7.2.3.2 Market size analysis, By Type, 2020-2027
  - 7.2.4 Spain
    - 7.2.4.1 Market size analysis, By End Use, 2020-2027
    - 7.2.4.2 Market size analysis, By Type, 2020-2027
  - 7.2.5 Italy
    - 7.2.5.1 Market size analysis, By End Use, 2020-2027
    - 7.2.5.2 Market size analysis, By Type, 2020-2027
  - 7.2.6 Rest of Europe
    - 7.2.6.1 Market size analysis, By End Use, 2020-2027
    - 7.2.6.2 Market size analysis, By Type, 2020-2027
  - 7.2.7 Research Dive Exclusive Insights
    - 7.2.7.1 Market attractiveness
    - 7.2.7.2 Competition heatmap
- 7.3 Asia-Pacific
  - 7.3.1 China
    - 7.3.1.1 Market size analysis, By End Use, 2020-2027
    - 7.3.1.2 Market size analysis, By Type, 2020-2027
  - 7.3.2 Japan
    - 7.3.2.1 Market size analysis, By End Use, 2020-2027
    - 7.3.2.2 Market size analysis, By Type, 2020-2027
  - 7.3.3 India
    - 7.3.3.1 Market size analysis, By End Use, 2020-2027
    - 7.3.3.2 Market size analysis, By Type, 2020-2027
  - 7.3.4 Australia
    - 7.3.4.1 Market size analysis, By End Use, 2020-2027
    - 7.3.4.2 Market size analysis, By Type, 2020-2027
  - 7.3.5 South Korea
    - 7.3.5.1 Market size analysis, By End Use, 2020-2027
    - 7.3.5.2 Market size analysis, By Type, 2020-2027
  - 7.3.6 Rest of Asia-Pacific
    - 7.3.6.1 Market size analysis, By End Use, 2020-2027
    - 7.3.6.2 Market size analysis, By Type, 2020-2027
  - 7.3.7 Research Dive Exclusive Insights
    - 7.3.7.1 Market attractiveness
    - 7.3.7.2 Competition heatmap
- 7.4 LAMEA
  - 7.4.1 Brazil
    - 7.4.1.1 Market size analysis, By End Use, 2020-2027
    - 7.4.1.2 Market size analysis, By Type, 2020-2027
  - 7.4.2 Saudi Arabia
    - 7.4.2.1 Market size analysis, By End Use, 2020-2027
    - 7.4.2.2 Market size analysis, By Type, 2020-2027
  - 7.4.3 UAE
    - 7.4.3.1 Market size analysis, By End Use, 2020-2027
    - 7.4.3.2 Market size analysis, By Type, 2020-2027
  - 7.4.4 South Africa
    - 7.4.4.1 Market size analysis, By End Use, 2020-2027
    - 7.4.4.2 Market size analysis, By Type, 2020-2027
  - 7.4.5 Rest of LAMEA
    - 7.4.5.1 Market size analysis, By End Use, 2020-2027
    - 7.4.5.2 Market size analysis, By Type, 2020-2027
  - 7.4.6 Research Dive Exclusive Insights
    - 7.4.6.1 Market attractiveness
    - 7.4.6.2 Competition heatmap
8. Competitive Landscape
- 8.1 Top winning strategies, 2020-2027
  - 8.1.1 By strategy
  - 8.1.2 By year
- 8.2 Strategic overview
- 8.3 Market share analysis, 2020-2027
9. Company Profiles
- 9.1 F. Hoffmann-La Roche AG
  - 9.1.1 Overview
  - 9.1.2 Business segments
  - 9.1.3 Product portfolio
  - 9.1.4 Financial performance
  - 9.1.5 Recent developments
  - 9.1.6 SWOT analysis
- 9.2 Quidel Corporation
  - 9.2.1 Overview
  - 9.2.2 Business segments
  - 9.2.3 Product portfolio
  - 9.2.4 Financial performance
  - 9.2.5 Recent developments
  - 9.2.6 SWOT analysis
- 9.3 Thermo Fisher Scientific
  - 9.3.1 Overview
  - 9.3.2 Business segments
  - 9.3.3 Product portfolio
  - 9.3.4 Financial performance
  - 9.3.5 Recent developments
  - 9.3.6 SWOT analysis
- 9.4 Abbott Laboratories
  - 9.4.1 Overview
  - 9.4.2 Business segments
  - 9.4.3 Product portfolio
  - 9.4.4 Financial performance
  - 9.4.5 Recent developments
  - 9.4.6 SWOT analysis
- 9.5 Hologic
  - 9.5.1 Overview
  - 9.5.2 Business segments
  - 9.5.3 Product portfolio
  - 9.5.4 Financial performance
  - 9.5.5 Recent developments
  - 9.5.6 SWOT analysis
- 9.6 Becton, Dickinson, and Company
  - 9.6.1 Overview
  - 9.6.2 Business segments
  - 9.6.3 Product portfolio
  - 9.6.4 Financial performance
  - 9.6.5 Recent developments
  - 9.6.6 SWOT analysis
- 9.7 DiaSorin S.p.A
  - 9.7.1 Overview
  - 9.7.2 Business segments
  - 9.7.3 Product portfolio
  - 9.7.4 Financial performance
  - 9.7.5 Recent developments
  - 9.7.6 SWOT analysis
- 9.8 Luminex Corporation
  - 9.8.1 Overview
  - 9.8.2 Business segments
  - 9.8.3 Product portfolio
  - 9.8.4 Financial performance
  - 9.8.5 Recent developments
  - 9.8.6 SWOT analysis
- 9.9 Meridian Bioscience
  - 9.9.1 Overview
  - 9.9.2 Business segments
  - 9.9.3 Product portfolio
  - 9.9.4 Financial performance
  - 9.9.5 Recent developments
  - 9.9.6 SWOT analysis
- 9.10 GenMark Diagnostics
  - 9.10.1 Overview
  - 9.10.2 Business segments
  - 9.10.3 Product portfolio
  - 9.10.4 Financial performance
  - 9.10.5 Recent developments
  - 9.10.6 SWOT analysis
- 9.11 SA Scientific
  - 9.11.1 Overview
  - 9.11.2 Business segments
  - 9.11.3 Product portfolio
  - 9.11.4 Financial performance
  - 9.11.5 Recent developments
  - 9.11.6 SWOT analysis
- 9.12 Sekisui Diagnostics
  - 9.12.1 Overview
  - 9.12.2 Business segments
  - 9.12.3 Product portfolio
  - 9.12.4 Financial performance
  - 9.12.5 Recent developments
  - 9.12.6 SWOT analysis
- 9.13 bioMérieux SA
  - 9.13.1 Overview
  - 9.13.2 Business segments
  - 9.13.3 Product portfolio
  - 9.13.4 Financial performance
  - 9.13.5 Recent developments
  - 9.13.6 SWOT analysis
- 9.14 Danaher Corporation
  - 9.14.1 Overview
  - 9.14.2 Business segments
  - 9.14.3 Product portfolio
  - 9.14.4 Financial performance
  - 9.14.5 Recent developments
  - 9.14.6 SWOT analysis
- 9.15 Siemens Healthineers
  - 9.15.1 Overview
  - 9.15.2 Business segments
  - 9.15.3 Product portfolio
  - 9.15.4 Financial performance
  - 9.15.5 Recent developments
  - 9.15.6 SWOT analysis
- 9.16 Tecan Trading AG
  - 9.16.1 Overview
  - 9.16.2 Business segments
  - 9.16.3 Product portfolio
  - 9.16.4 Financial performance
  - 9.16.5 Recent developments
  - 9.16.6 SWOT analysis
- 9.17 ELITech
  - 9.17.1 Overview
  - 9.17.2 Business segments
  - 9.17.3 Product portfolio
  - 9.17.4 Financial performance
  - 9.17.5 Recent developments
  - 9.17.6 SWOT analysis
- 9.18 Mast Group
  - 9.18.1 Overview
  - 9.18.2 Business segments
  - 9.18.3 Product portfolio
  - 9.18.4 Financial performance
  - 9.18.5 Recent developments
  - 9.18.6 SWOT analysis
- 9.19 altona Diagnostics
  - 9.19.1 Overview
  - 9.19.2 Business segments
  - 9.19.3 Product portfolio
  - 9.19.4 Financial performance
  - 9.19.5 Recent developments
  - 9.19.6 SWOT analysis
- 9.20 Coris BioConcept
  - 9.20.1 Overview
  - 9.20.2 Business segments
  - 9.20.3 Product portfolio
  - 9.20.4 Financial performance
  - 9.20.5 Recent developments
  - 9.20.6 SWOT analysis
- 9.21 Genome Diagnostics
  - 9.21.1 Overview
  - 9.21.2 Business segments
  - 9.21.3 Product portfolio
  - 9.21.4 Financial performance
  - 9.21.5 Recent developments
  - 9.21.6 SWOT analysis
- 9.22 Germaine Laboratories
  - 9.22.1 Overview
  - 9.22.2 Business segments
  - 9.22.3 Product portfolio
  - 9.22.4 Financial performance
  - 9.22.5 Recent developments
  - 9.22.6 SWOT analysis
- 9.23 Response Biomedical
  - 9.23.1 Overview
  - 9.23.2 Business segments
  - 9.23.3 Product portfolio
  - 9.23.4 Financial performance
  - 9.23.5 Recent developments
  - 9.23.6 SWOT analysis
- 9.24 TAUNS Laboratories
  - 9.24.1 Overview
  - 9.24.2 Business segments
  - 9.24.3 Product portfolio
  - 9.24.4 Financial performance
  - 9.24.5 Recent developments
  - 9.24.6 SWOT analysis
- 9.25 TRUPCR
  - 9.25.1 Overview
  - 9.25.2 Business segments
  - 9.25.3 Product portfolio
  - 9.25.4 Financial performance
  - 9.25.5 Recent developments
  - 9.25.6 SWOT analysis

Research Methodology

Purchase Options

Individual License $4290 Corporate License $4920

Personalize this research

Triangulate with your own data
Request your format and definition
Get a deeper dive on a specific application, geography, customer or competitor

10% Off on Customization

Speak To The Analyst
Or Schedule A Call

+ 1-888-961-4454 Toll - Free
support@researchdive.com

Influenza Diagnostic Tests Market Report

Influenza Diagnostic Tests Market, by End Use (Hospitals, Clinical Laboratories, Other End-User), Type (Traditional Diagnostic Tests, Molecular Diagnostic Tests): Global Opportunity Analysis and Industry Forecast, 2020-2027

1. RESEARCH METHODOLOGY

1.1. Desk Research

1.2. Real time insights and validation

1.3. Forecast model

1.4. Assumptions and forecast parameters

1.5. Market size estimation

1.5.1. Top-down approach

1.5.2. Bottom-up approach

2. REPORT SCOPE

2.1. Market definition

2.2. Key objectives of the study

2.3. Report overview

2.4. Market segmentation

2.5. Overview of the impact of COVID-19 on Global Influenza Diagnostic Tests Market

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

4.1. Introduction

4.2. Growth impact forces

4.2.1. Drivers

4.2.2. Restraints

4.2.3. Opportunities

4.3. Market value chain analysis

4.3.1. List of raw material suppliers

4.3.2. List of manufacturers

4.3.3. List of distributors

4.4. Innovation & sustainability matrices

4.4.1. Technology matrix

4.4.2. Regulatory matrix

4.5. Porter’s five forces analysis

4.5.1. Bargaining power of suppliers

4.5.2. Bargaining power of consumers

4.5.3. Threat of substitutes

4.5.4. Threat of new entrants

4.5.5. Competitive rivalry intensity

4.6. PESTLE analysis

4.6.1. Political

4.6.2. Economical

4.6.3. Social

4.6.4. Technological

4.6.5. Environmental

4.7. Impact of COVID-19 on Influenza Diagnostic Tests Market

4.7.1. Pre-covid market scenario

4.7.2. Post-covid market scenario

5. Influenza Diagnostic Tests Market, By End Use

5.1. Overview

5.2 Hospitals

5.2.1 Definition, key trends, growth factors, and opportunities

5.2.2 Market size analysis, by region, 2020-2027

5.2.3 Market share analysis, by country, 2020-2027

5.3 Clinical Laboratories

5.3.1 Definition, key trends, growth factors, and opportunities

5.3.2 Market size analysis, by region, 2020-2027

5.3.3 Market share analysis, by country, 2020-2027

5.4 Other End-User

5.4.1 Definition, key trends, growth factors, and opportunities

5.4.2 Market size analysis, by region, 2020-2027

5.4.3 Market share analysis, by country, 2020-2027

5.5 Research Dive Exclusive Insights

5.5.1 Market attractiveness

5.5.2 Competition heatmap

6. Influenza Diagnostic Tests Market, By Type

6.1. Overview

6.2 Traditional Diagnostic Tests

6.2.1 Definition, key trends, growth factors, and opportunities

6.2.2 Market size analysis, by region, 2020-2027

6.2.3 Market share analysis, by country, 2020-2027

6.3 Molecular Diagnostic Tests

6.3.1 Definition, key trends, growth factors, and opportunities

6.3.2 Market size analysis, by region, 2020-2027

6.3.3 Market share analysis, by country, 2020-2027

6.4 Research Dive Exclusive Insights

6.4.1 Market attractiveness

6.4.2 Competition heatmap

7. Influenza Diagnostic Tests Market, By Region

7.1 North America

7.1.1 U.S

7.1.1.1 Market size analysis, By End Use, 2020-2027

7.1.1.2 Market size analysis, By Type, 2020-2027